Ginkgo Bioworks Holdings (NYSE:DNA)報告的季度每股虧損爲$(2.00)，低於分析師普遍預期的$(1.77)，差距爲12.99%。相比去年同期每股虧損$(4.28)，這是53.27%的改善。該公司本季度報告銷售額爲4385萬美元，未達到分析師普遍預期的4446萬美元，差距爲1.39%。相比去年同期的3476萬美元，這一數據增長了26.16%。

以上內容來自Benzinga Earnings專欄，原文如下：

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 53.27 percent increase over losses of $(4.28) per share from the same period last year. The company reported quarterly sales of $43.85 million which missed the analyst consensus estimate of $44.46 million by 1.39 percent. This is a 26.16 percent increase over sales of $34.76 million the same period last year.